Home > PJ (current issue) > News / Daily News | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7297 p531-536
1 May 2004

This section
Reprint   Photocopy

PDF 290K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events   Conferences

531 Concerns raised as new pharmacy course launched Kingston University received approval for its MPharm degree course from the Royal Pharmaceutical Society this week. However, the Society expressed concerns over how new school openings might impact on pharmacy education ...more

531 Access to health care to be easier in Europe Patients are to have easier access to health care in other European countries under plans outlined by the European Commission ...more

531 New ID cards could protect NHS resources Use of ID cards would benefit the NHS, health minister John Hutton said this week ...more

531 MHRA publishes its first corporate plan and aims to tackle medicines information Improving the quality of information available to the public about medicines is a key initiative set out by the Medicines and Healthcare products Regulatory Agency in the first ever five-year corporate plan it has published ...more

532 CRC closures a disaster, say design researchers Traditional child-resistant containers (CRCs) are a design disaster, with most adults having to struggle to open them, according to a study publicised this week in the journal of the Engineering and Physical Sciences Research Council ...more

532 Legislation will delay child medicines claim European legislation on children's medicines will delay their availability, according to the Association of the British Pharmaceutical Industry ...more

532 Nottingham launches locally focussed pharmacy strategy Nottingham City Primary Care Trust launched its community pharmacy strategy on 27 April ...more

532 Weak evidence for children's migraine treatment Published evidence supporting the use of migraine treatments in children is weak, according to the April issue of Drug and Therapeutics Bulletin ...more

532 Zinc improves behaviour in ADHD Adding zinc supplements to standard methylphenidate treatment for attention-deficit hyperactivity disorder in children seems to be beneficial, according to researchers from Iran ...more

533 First pharmacist prescription written in primary care Last week, a pharmacist in Scotland became the first to write a prescription for use in primary care ...more

533 NHS may run out of vaccines, Parliamentary committee warns Reliance on a small number of suppliers means that the NHS risks running out of many essential vaccines ...more

533 650 million prescriptions dispensed in England last year Nearly 650 million prescriptions for medicines worth over £7.5bn were dispensed by community pharmacies and dispensing doctors in England in 2003, according to detailed statistics issued by the Department of Health. The number of prescriptions was up 5.3 per cent on the previous year, while the cost rose by 9.7 per cent ...more

534 NICE issues guidance on newer epilepsy drugs Guidance on using newer drugs for treating epilepsy in children has been issued by the National Institute for Clinical Excellence. It recommends the use of newer antiepileptic agents in children who have not benefited from treatment with older drugs, or for whom the older drugs are unsuitable ...more

534 Unpublished studies change risk benefits of SSRIs in children Inclusion of unpublished studies in assessing the safety of selective serotonin reuptake inhibitors in children can change the risk benefit profiles of these drugs. So finds a study by UK researchers, including staff from the National Collaborating Centre for Mental Health ...more

534 Paroxetine review makes safety warnings A number of recommendations on paroxetine use have been made following a European review of the product by the Committee for Proprietary Medicinal Products and the European Agency for the Evaluation of Medicinal Products ...more

535 Lack of distinction between “z” drugs in insomnia Treatment of insomnia should be driven by the cost of treatment because of a lack of compelling evidence to distinguish between zaleplon, zolpidem, zopiclone and shorter-acting benzodiazepines ...more

535 Electronic Drug Tariff launched on 1 May An electronic version of the Drug Tariff will be launched on 1 May, the Prescription Pricing Authority announced this week ...more

535 Amlodipine reimbursement On 1 May the category for amlodipine in part VIII of the Drug Tariff will change from category C (priced on the basis of a particular brand or particular manufacturer) to category A (drugs which are readily available) ...more

535 BTS/SIGN asthma update Inhaled steroids should be used in milder cases of asthma than previously recommended, says the British Thoracic Society and Scottish Intercollegiate Guidelines Network ...more

535 Adherence to BP treatment Making dosing regimens simpler can improve adherence to blood pressure lowering medication by up to 20 per cent, a new study shows ...more

535 Lipid levels higher in winter More people may be diagnosed as having hypercholesterolaemia during the winter months, say researchers who have found blood lipid levels to be higher at this time of year ...more

535 Sanofi and Aventis agreement Sanofi-Synthélabo and Aventis are to form a new company, Sanofi-Aventis, if the shareholders of Aventis agree to an offer made by Sanofi-Synthélabo ...more

536 Technicians make progress on Agenda for Change Five national profiles for pharmacy technicians have now been agreed under Agenda for Change ...more

536 NHS fraud team welcomes the recent striking-off of two pharmacists NHS fraud investigators have welcomed recent decisions by the Royal Pharmaceutical Society’s Statutory Committee to strike off two pharmacists for defrauding the NHS ...more

536 PSNC in talks over alarms for pharmacists Discussions are taking place between the Pharmaceutical Services Negotiating Committee and the NHS Counter Fraud and Security Management Service about the provision of personal attack alarms for community pharmacists ...more

536 Call for applicants for award for cross-sector NHS projects Pharmacists wishing to develop evidence-based services that bridge the divide between the hospital and community sectors are invited to apply for an award from the joint National Pharmaceutical Association-Guild of Healthcare Pharmacists scheme, which is endorsed by the Royal Pharmaceutical Society ...more

536 London secures funding for CPD support London Pharmacy Education and Training has secured funding to continue support for pharmacy staff implementing continuing professional development in NHS organisations in London, Hertfordshire and Essex ...more

Back to Top


©The Pharmaceutical Journal